Welcome to our dedicated page for Tabula Rasa Heal news (Ticker: TRHC), a resource for investors and traders seeking the latest updates and insights on Tabula Rasa Heal stock.
Tabula Rasa HealthCare, Inc. (TRHC) generates news that reflects its focus on medication safety, pharmacy services and technology-enabled solutions for value-based care organizations. Company announcements highlight how TRHC works with health plans, at-risk provider groups and programs such as the Program of All-Inclusive Care for the Elderly (PACE) to address medication-related risks and support complex patient populations.
News coverage for TRHC often includes financial results and operational updates. Earnings releases describe trends in medication revenue and technology-enabled solutions revenue, with commentary on factors such as PACE census growth, revenue per PACE participant and changes in gross margin. These updates also discuss non-GAAP measures like adjusted EBITDA, adjusted gross profit and adjusted operating income or loss, which TRHC presents as supplemental indicators of performance.
Another key category of TRHC news involves strategic and corporate developments. The company has reported the divestiture of non-core businesses such as SinfoníaRx and DoseMe, and it announced a definitive agreement to be acquired by Nautic Partners and combined with ExactCare Pharmacy. Corporate updates have also covered leadership changes, including the appointment of a new President and Chief Executive Officer and the addition of a Chief Legal Officer and Corporate Secretary.
TRHC also issues news about client relationships and solution deployments. For example, the company announced that Mountain Empire PACE signed agreements for personalized pharmacy services and pharmacy benefit management, building on existing use of PACElogic integrated technology solutions and PeakTPA administration services. Such stories illustrate how TRHC’s offerings are applied in real-world care settings.
Investors, analysts and healthcare professionals can use this news stream to follow TRHC’s financial performance, corporate actions, partnerships and the evolution of its medication safety and pharmacy care solutions over time.
ZimVie will replace Tabula Rasa Healthcare in the S&P SmallCap 600 index on March 2, 2022. This change comes as Zimmer Biomet Holdings spins off ZimVie, effective March 1, 2022. Post spin-off, Zimmer Biomet will continue to be a part of the S&P 500 index. Tabula Rasa Healthcare is being removed due to its lack of representation in the small-cap market.
Tabula Rasa HealthCare (TRHC) has signed an agreement with HopeWest to implement its CareVention HealthCare services, enhancing medication safety and healthcare for elderly patients. The services include risk adjustment, pharmacy services, and electronic health record technology, aimed at optimizing PACE programs. HopeWest, which began its PACE operations in October 2021, acknowledges the critical support from TRHC for its successful launch. This partnership marks continued growth in TRHC's PACE initiatives, demonstrating its commitment to improving patient outcomes and expanding its healthcare solutions.
Tabula Rasa HealthCare (TRHC) will host a conference call on February 25, 2022, at 8:30 a.m. EDT, to discuss its fourth quarter and full year 2021 operating results. The financial results will be released on February 24, 2022, after market close. Key executives will lead the call, providing insights into the company's performance. Interested parties can access the call through TRHC's website or by dialing in with a specified passcode. The company, which offers medication safety solutions, aims to optimize patient care and reduce adverse drug events.
On February 9, 2022, Tabula Rasa HealthCare (TRHC) announced a non-binding Letter of Intent to sell its DoseMeRx solution. This decision aligns with the company's strategy to focus on core assets and enhance shareholder value. According to CEO Calvin H. Knowlton, the move is intended to sharpen TRHC's focus on its primary mission while unlocking value in non-core assets. DosMeRx provides advanced precision dosing tools to improve patient outcomes in medication management.
Tabula Rasa HealthCare (TRHC) has announced a five-year contract renewal with Evernorth, enhancing the use of its Medication Therapy Management (MTM) programs. This agreement builds on a decade-long partnership, with TRHC providing innovative solutions that have achieved over $700 million in cost savings through 9 million medication-related interventions. TRHC will continue to deliver MTM services to millions of Medicare, Medicaid, and commercial members, utilizing its extensive pharmacy network to improve member engagement and satisfaction.
Tabula Rasa HealthCare, Inc. (TRHC) announced results from two peer-reviewed studies focusing on opioid-drug interactions using MedWise® Science. The first study published in the Journal of Personalized Medicine revealed that patients on opioids who also take interacting medications face increased medical expenses and risks of adverse events. The second study in the Journal of Palliative Medicine highlighted how genetic data can enhance medication safety for opioid users, with 85% of clinicians reporting improved patient care through MedWise's decision support tools.
Tabula Rasa HealthCare (TRHC) hosted its 2021 CareVention HealthCare Advisory Summit in Orlando, focusing on growth opportunities in the Program of All-Inclusive Care for the Elderly (PACE). Key discussions included the PACE Plus Act aimed at enhancing site approvals and affordability for Medicare beneficiaries. TRHC emphasized the increasing role of technology in home-based care, with industry leaders advocating for innovative services. The summit, now in its third year, included both in-person and virtual participation, facilitating valuable networking.
Tabula Rasa HealthCare (TRHC) will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29 to December 2, 2021. Co-President Brian W. Adams and Senior VP Frank Sparacino will engage in a fireside discussion. This session can be viewed on TRHC's Investor site and the conference site. Presentations can be accessed until December 2, 2021.
Tabula Rasa HealthCare, Inc. (TRHC) has renewed a five-year contract with Rocky Mountain PACE, enhancing medication management services for over 800 participants in Colorado Springs. The partnership utilizes TRHC's CareKinesis, which offers personalized medication management and 24/7 clinical pharmacist support, improving medication safety and adherence. Rocky Mountain PACE has successfully implemented these services since 2018, contributing to better participant outcomes. The ongoing collaboration highlights TRHC's strong position in medication safety solutions aimed at reducing adverse drug events.
Tabula Rasa HealthCare (TRHC) announced significant organizational changes aimed at strengthening its corporate structure and promoting strategic growth, particularly for its MedWise solutions. Effective immediately, Brian W. Adams is appointed Co-President while retaining his CFO role. This move is designed to unify critical functions within the company and allow CEO Calvin H. Knowlton to focus on broader strategic goals. Adams brings extensive experience in strategic acquisitions and financial optimization, while Orsula V. Knowlton will also enhance diversity efforts alongside her marketing role.